These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7478429)

  • 41. Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers.
    Koreth J; Bakkenist CJ; McGee JO
    Oncogene; 1997 Jan; 14(4):431-7. PubMed ID: 9053840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of 14q31-q32.2 in renal cell carcinoma is associated with high malignancy grade and poor survival.
    Alimov A; Sundelin B; Wang N; Larsson C; Bergerheim U
    Int J Oncol; 2004 Jul; 25(1):179-85. PubMed ID: 15202004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
    Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
    Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas.
    Chuaqui RF; Sanz-Ortega J; Vocke C; Linehan WM; Sanz-Esponera J; Zhuang Z; Emmert-Buck MR; Merino MJ
    Cancer Res; 1995 Nov; 55(21):4995-8. PubMed ID: 7585541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
    Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High frequency of allelic imbalance at chromosome region 16q22-23 in human breast cancer: correlation with high PgR and low S phase.
    Skirnisdottir S; Eiriksdottir G; Baldursson T; Barkardottir RB; Egilsson V; Ingvarrson S
    Int J Cancer; 1995 Apr; 64(2):112-6. PubMed ID: 7615353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for involvement of BRCA1 in sporadic breast carcinomas.
    Cropp CS; Nevanlinna HA; Pyrhönen S; Stenman UH; Salmikangas P; Albertsen H; White R; Callahan R
    Cancer Res; 1994 May; 54(10):2548-51. PubMed ID: 8168077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of heterozygosity at BRCA1, TP53, nm-23 and other loci on chromosome 17q in human breast carcinoma.
    Saleh EM; Wahab AH; Elhouseini ME; Eisa SS
    J Egypt Natl Canc Inst; 2004 Mar; 16(1):62-8. PubMed ID: 15717000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Analysis on loss of heterozygosity of chromosome 17p13.3 in hepatocellular carcinoma and construction of genomic contig in the deleted region].
    Zhao X; Wan D; Jiang H
    Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):377-80. PubMed ID: 11778272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
    Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
    Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deletion of two separate regions on chromosome 3p in breast cancers.
    Chen LC; Matsumura K; Deng G; Kurisu W; Ljung BM; Lerman MI; Waldman FM; Smith HS
    Cancer Res; 1994 Jun; 54(11):3021-4. PubMed ID: 7910519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic alteration mapping on chromosome 7 in primary breast cancer.
    Bièche I; Khodja A; Driouch K; Lidereau R
    Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variables.
    Kristjansson AK; Eiriksdottir G; Ragnarsson G; Sigurdsson A; Gudmundsson J; Barkardottir RB; Jonasson JG; Egilsson V; Ingvarsson S
    Anticancer Res; 1997; 17(1A):93-8. PubMed ID: 9066635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.
    Saito H; Inazawa J; Saito S; Kasumi F; Koi S; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
    Cancer Res; 1993 Jul; 53(14):3382-5. PubMed ID: 8100738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of heterozygosity in thyroid hormone receptor beta in invasive breast cancer.
    Ling Y; Li Q; Yang H; Wang Y; Tang F; Kang H; Wang Y
    Tumori; 2015; 101(5):572-7. PubMed ID: 26350179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of heterozygosity at the TP53 gene: independent occurrence from genetic instability events in node-negative breast cancer.
    Lizard-Nacol S; Riedinger JM; Lizard G; Glasser AL; Coudray N; Chaplain G; Guerrin J
    Int J Cancer; 1997 Aug; 72(4):599-603. PubMed ID: 9259397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.
    Devilee P; van Vliet M; van Sloun P; Kuipers Dijkshoorn N; Hermans J; Pearson PL; Cornelisse CJ
    Oncogene; 1991 Sep; 6(9):1705-11. PubMed ID: 1681492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.